Cesium decorporation

Cesium decorporation

NU02 Cesium decorporation 137Cs is gamma and beta emitting by-product of uranium fission. Large quantities of 137Cs were released into the atmosphere during the Chernobyl and Fukushima disasters. 137Cs is water soluble and therefore can travel large distances from the...
AONYS® drug delivery technology

AONYS® drug delivery technology

AONYS® is a mix of lipidic components that spontaneously assemble into a water-in-oil microemulsion. The active agent is solubilized in the aqueous phase of the microemulsion, within reverse micelles of 4 to 5 nm in diameter. AONYS® allows the administration of low...
Drug to treat neurodegenerative diseases

Drug to treat neurodegenerative diseases

NanoLithium® (NP03) is a disease-modifying nano dose formulation of lithium citrate in an AONYS® reverse microemulsion. NP03 allows the delivery of lithium citrate to all tissues with a strong therapeutic efficacy at doses two orders of magnitude lower than those used...
Cesium decorporation

Cesium decorporation

Directly linked to 137Cs are numerous diseases not only limited to the increased prevalence of cancers (e.g. neurological diseases). Increases in premature births and birth malformations have been observed over a very wide geographical area. Children are particularly...